There are so many ways you can help make a difference in the lives of patients and families today.
This research competition is an opportunity for students to showcase their work to other scientists, researchers, and professionals attending the Virtual Brain Tumour Research Symposium.
Students will have the opportunity to create a research proposal, practice presentation skills and receive constructive feedback from a panel that will include physicians and researchers.
Our virtual lab tours give an exclusive look at the laboratories of change-makers in the pediatric brain tumour research field, including:
Dr. Sheila Singh Lab – McMaster University (Hamilton, ON)
Dr. Marshall Pitz Lab – CancerCare Manitoba (Winnipeg, MB)
Dr. Lisa Porter Lab – University of Windsor (Windsor, ON)
Dr. Derek Tsang – “Re-irradiation for childhood brain tumours”
Dr. Vijay Ramaswamy – “What is ependymoma in 2021?”
Brain Tumour Foundation of Canada partners with the Brain Tumor Funders’ Collaborative to extend the impact of research dollars.
Five North American funding organizations make up the Brain Tumor Funders’ Collaborative. The organization includes Brain Tumour Foundation of Canada along with five other non-profit, philanthropic and advocacy organizations from the United States. By working together we can accelerate progress in brain tumor research. The groups have worked together to fund two previous initiatives (details below) and are now exploring a third joint project. When this is finalized, the projects details, and any applicable calls for applications will be posted here.
The members of the Brain Tumour Funders’ Collaborative are:
In January 2019 the BTFC announced $3 million in grants to four multi-institutional teams of researchers and clinicians studying immunotherapy in primary brain tumours. Read the Press Release here.
The four funded projects will examine vaccination strategies, the tumour’s micro-environment, anti-tumour T-cells, and personalized immunotherapy approaches. They were selected during a multi-stage review process from more than 79 responses to the BTFC call for proposals.
The following institutions will be receiving $750,000 BTFC grants over the next three years:
Active vaccination and the timing of checkpoint blockade dictate effective immunotherapy for glioblastoma
David Geffen School of Medicine at UCLA
Project Manager: Robert Prins
Harnessing the brain tumour immune-microenvironment to enhance therapeutic efficacy
Project Manager: Daniela Quail
Interrogating anti-tumor T-cells To develop adoptive cell transfer (ACT) Immunotherapy for pediatric high-grade gliomas
UPMC Children’s Hospital of Pittsburgh
Project Manager: Gary Kohanbash
Three dimensional immuno-genomics approach to personalized neoantigen-based immunotherapy
University of California, San Francisco
Project Manager: Joseph Costello